Artificial intelligence (AI) continues to revolutionise healthcare, and dermatology is evolving with it. Recent data values the AI-powered drug discovery market in dermatology at USD 234.7 million in 2024. Experts project it will grow to USD 1,924.6 million by 2034, fuelled by a strong CAGR of 24.2 per cent from 2025 to 2034. Transforming dermatology with AI AI-driven drug discovery ...
Alkem Laboratories Ltd expands its presence in high-growth therapeutic areas with the acquisition of Adroit Biomed and Bombay Ortho Industries. These acquisitions will enhance Alkem’s dermatology and cosmetology portfolio while expanding its footprint in the medical device sector. Adroit Biomed acquisition The company will acquire Adroit Biomed, a company specialising in dermatology and cosmetology, for Rs 140 crore in two ...
Emcure Pharmaceuticals has introduced Emcutix Biopharmaceuticals, a wholly-owned subsidiary focused entirely on dermatology. This new venture aims to expand Emcure’s portfolio by offering innovative dermatology solutions that address both therapeutic and aesthetic skin care needs. Leveraging Emcure’s strong presence in the healthcare industry, the company will provide advanced dermatological products that enhance the skincare market in India. Moreover, the subsidiary ...